Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019

Published:2021-03-15 Issue:2 Volume:8 Page:253-262
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Wei Shaokui^ORCID,Niu Manette T.^ORCID,Dores Graça M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-021-00242-x.pdf

Reference30 articles.

1. U.S. Food and Drug Administration. DigiFab (Digoxin Immune Fab [Ovine]). https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/digifab. Accessed 20 July 2020.

2. Butler VP Jr, Chen JP. Digoxin-specific antibodies. Proc Natl Acad Sci USA. 1967;57(1):71–8. https://doi.org/10.1073/pnas.57.1.71.

3. Smith TW, Haber E, Yeatman L, Butler VP Jr. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976;294(15):797–800. https://doi.org/10.1056/NEJM197604082941501.

4. Schaeffer TH, Mlynarchek SL, Stanford CF, Delgado J, Holstege CP, Olsen D, et al. Treatment of chronically digoxin-poisoned patients with a newer digoxin immune fab—a retrospective study. J Am Osteopath Assoc. 2010;110(10):587–92.

5. Ward SB, Sjostrom L, Ujhelyi MR. Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus Digibind. Ther Drug Monit. 2000;22(5):599–607. https://doi.org/10.1097/00007691-200010000-00016.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidotes to nonreptile animal toxins;Antidotes to Toxins and Drugs;2024

2. A suicide attempt by ingestion of oleander leaves and treatment with digoxin-specific Fab antibody fragments;Archives of Industrial Hygiene and Toxicology;2023-12-01

3. Digoxin-specific antibodies: a novel dosing strategy;Netherlands Heart Journal;2023-10-20

4. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care;Circulation;2023-10-17

5. Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study;Frontiers in Public Health;2023-01-17